Thoughts generated by the annual meeting of the American Society of Clinical Pharmacology and Therapeutics

Ocular Surface

Volumn 2, Issue 3, 2004, Pages 212-213

  Novack, Gary D ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

'EPHEDRA'; ANALGESIC AGENT; ANESTHETIC AGENT; ANTIBIOTIC AGENT; CARDIOVASCULAR AGENT; EPHEDRINE; MUSCARINIC RECEPTOR BLOCKING AGENT; OPIATE;

AQUEOUS HUMOR; CONFERENCE PAPER; DIET SUPPLEMENTATION; DRUG APPROVAL; DRUG EFFICACY; DRUG FATALITY; DRUG LEGISLATION; DRUG MARKETING; FOOD AND DRUG ADMINISTRATION; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; MEDICAL RESEARCH; MEDICAL SOCIETY; MYOPIA; NONHUMAN; OPHTHALMOLOGY; PUPIL; QT PROLONGATION; RISK BENEFIT ANALYSIS; SAFETY; STROKE; SUDDEN DEATH;

EID: 24644506217     PISSN: 15420124     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1542-0124(12)70063-0     Document Type: Conference Paper

References (2)

1. Sheiner LB. Learning versus confirming in clinical drug development. Clin Pharm Ther 1997;61:275-91.
2. Sheiner LB. Intellectual health of clinical drug evaluation. Clin Pharm Ther 1991;50:4-9.